Abstract
This paper is the first report describing the characterization of local diatomite of Caldiran-Van region (Eastern Anatolia, Turkey). Special attention was paid to the ability of its electroanalytical performance at modified electrodes and to the potential application of diatomite-modified electrode. For this purpose, the determination of Naratriptan which is a novel oral triptan (5-hydroxytryptamine receptor agonist) in migraine treatment, by means of a carbon paste electrode modified with 10% (w/w) of diatomite was studied using cyclic and square-wave voltammetry. The experimental conditions that affect the electrode reaction process were studied in terms of pH of the supporting electrolyte, scan rate, accumulation variables, modifier composition and square-wave parameters. Using square-wave stripping mode, the drug yielded a well-defined voltammetric response in Britton-Robinson buffer, pH 4.0 at 0.84 V (vs Ag/AgCl) (a preconcentration step being carried out with an open circuit at 120 s). The process could be used to determine Naratriptan concentrations in the range 5x10-7 – 9x10-7 M, with a detection limit of 1.25x10-7 M (46.5 μg L-1). The applicability of the method to spiked human urine samples was illustrated.
Keywords: Diatomite, characterization, modified carbon paste electrode, cyclic voltammetry, square-wave stripping voltammetry, naratriptan, urine
Combinatorial Chemistry & High Throughput Screening
Title:The Natural Diatomite from Çaldıran-Van (Turkey): Electroanalytical Application to Antimigraine Compound Naratriptan at Modified Carbon Paste Electrode§
Volume: 13 Issue: 8
Author(s): Necla Caliskan, Eda Sogut, Cafer Saka, Yavuz Yardim and Zuhre Senturk
Affiliation:
Keywords: Diatomite, characterization, modified carbon paste electrode, cyclic voltammetry, square-wave stripping voltammetry, naratriptan, urine
Abstract: This paper is the first report describing the characterization of local diatomite of Caldiran-Van region (Eastern Anatolia, Turkey). Special attention was paid to the ability of its electroanalytical performance at modified electrodes and to the potential application of diatomite-modified electrode. For this purpose, the determination of Naratriptan which is a novel oral triptan (5-hydroxytryptamine receptor agonist) in migraine treatment, by means of a carbon paste electrode modified with 10% (w/w) of diatomite was studied using cyclic and square-wave voltammetry. The experimental conditions that affect the electrode reaction process were studied in terms of pH of the supporting electrolyte, scan rate, accumulation variables, modifier composition and square-wave parameters. Using square-wave stripping mode, the drug yielded a well-defined voltammetric response in Britton-Robinson buffer, pH 4.0 at 0.84 V (vs Ag/AgCl) (a preconcentration step being carried out with an open circuit at 120 s). The process could be used to determine Naratriptan concentrations in the range 5x10-7 – 9x10-7 M, with a detection limit of 1.25x10-7 M (46.5 μg L-1). The applicability of the method to spiked human urine samples was illustrated.
Export Options
About this article
Cite this article as:
Caliskan Necla, Sogut Eda, Saka Cafer, Yardim Yavuz and Senturk Zuhre, The Natural Diatomite from Çaldıran-Van (Turkey): Electroanalytical Application to Antimigraine Compound Naratriptan at Modified Carbon Paste Electrode§, Combinatorial Chemistry & High Throughput Screening 2010; 13 (8) . https://dx.doi.org/10.2174/138620710791920356
DOI https://dx.doi.org/10.2174/138620710791920356 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Concurrent Use of Cannabis and Alcohol: Neuropsychiatric Effect Consequences
CNS & Neurological Disorders - Drug Targets Role of Dopamine Signaling in Drug Addiction
Current Topics in Medicinal Chemistry Progression of Alzheimer-type Neurofibrillary Tangles is Related to the Proximodistal Segments of the Hemispheric Arteries
Current Alzheimer Research Diagnosis, Treatment, and New Developments in Preeclampsia
Current Women`s Health Reviews Editorial (Thematic Issue: Linkage of CNS and Immunology with Psychology: Searching for New Pharmacological Targets)
CNS & Neurological Disorders - Drug Targets Dual COX-Inhibitors: The Answer is NO?
Current Topics in Medicinal Chemistry Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Foreword: The Year in Review: Comments on Plants, Cyclodextrins, Microbiota, and Diabetes
Current Pharmaceutical Design Vitamin D Deficiency: Universal Risk Factor for Multifactorial Diseases?
Current Drug Targets UBQ-8i Polymorphism is not An Independent Risk Factor for Mild Cognitive Impairment and Alzheimer’s Disease in APOE-4 Carriers
Current Alzheimer Research Subcutaneous Immunoglobulins: A Promising Alternative for Immunomodulation?
Current Pharmaceutical Design Exploring the Potential of Neuroproteomics in Alzheimer's Disease
Current Topics in Medicinal Chemistry Drainage of Cerebral Abscesses Prior to Valve Replacement in Stable Patients with Acute Left-Sided Infective Endocarditis
CNS & Neurological Disorders - Drug Targets Polarization of Calcium Signaling and Fluid Secretion in Salivary Gland Cells
Current Medicinal Chemistry Interaction of Cyclosporine A and the Renin-Angiotensin System New Perspectives
Current Drug Metabolism Glycoconjugates: Roles in Neural Diseases Caused by Exogenous Pathogens
CNS & Neurological Disorders - Drug Targets Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics
Current Neuropharmacology Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy A Pharmacophore Model Specific to Active Site of CYP1A2 with a Novel Molecular Modeling Explorer and CoMFA
Medicinal Chemistry Morin Inhibits Ovarian Cancer Growth through the Inhibition of NF-κB Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry